Phyla

company

About

Phyla is developing alternative therapies for antibiotics.

  • 1 - 10

Details

Last Funding Type
Non-Equity Assistant
Industries
Biotechnology,Health Care,Wellness
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Phyla is developing alternative therapies for antibiotics. The focus of most microbiome efforts is to discover beneficial bacteria to add to the microbiome, in order to cure disease or maintain health. However others lack a subtractive function that can remove harmful or disease-causing bacteria, that would allow the microbiome to rebalance and achieve a stable healthy state. Using bacteriophages as a foundation, they are developing a powerful platform that allows us to selectively 'subtract' bad bacteria without harming the good strains present in the community. It's a bit like using a sniper instead of a grenade to take out a bad guy in a crowd of people.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Phyla has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2021 from a Non-Equity Assistant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2021 Non-Equity Assistant 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Phyla is funded by 1 investors. Newchip are the most recent investors.
Investor Name Lead Investor Funding Round
Newchip Non-Equity Assistant